6.
Siegfried J, Hershberger P, Stabile L
. Estrogen receptor signaling in lung cancer. Semin Oncol. 2009; 36(6):524-31.
PMC: 2818861.
DOI: 10.1053/j.seminoncol.2009.10.004.
View
7.
Neumann T, Rasmussen M, Heitmann B, Tonnesen H
. Gold standard program for heavy smokers in a real-life setting. Int J Environ Res Public Health. 2013; 10(9):4186-99.
PMC: 3799509.
DOI: 10.3390/ijerph10094186.
View
8.
Buenrostro J, Giresi P, Zaba L, Chang H, Greenleaf W
. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013; 10(12):1213-8.
PMC: 3959825.
DOI: 10.1038/nmeth.2688.
View
9.
Corces M, Granja J, Shams S, Louie B, Seoane J, Zhou W
. The chromatin accessibility landscape of primary human cancers. Science. 2018; 362(6413).
PMC: 6408149.
DOI: 10.1126/science.aav1898.
View
10.
Shaykhiev R, Otaki F, Bonsu P, Dang D, Teater M, Strulovici-Barel Y
. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci. 2010; 68(5):877-92.
PMC: 3838912.
DOI: 10.1007/s00018-010-0500-x.
View
11.
Casal-Mourino A, Valdes L, Barros-Dios J, Ruano-Ravina A
. Lung cancer survival among never smokers. Cancer Lett. 2019; 451:142-149.
DOI: 10.1016/j.canlet.2019.02.047.
View
12.
Landi M, Dracheva T, Rotunno M, Figueroa J, Liu H, Dasgupta A
. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One. 2008; 3(2):e1651.
PMC: 2249927.
DOI: 10.1371/journal.pone.0001651.
View
13.
Sun S, Schiller J, Gazdar A
. Lung cancer in never smokers--a different disease. Nat Rev Cancer. 2007; 7(10):778-90.
DOI: 10.1038/nrc2190.
View
14.
Soini Y
. Claudins in lung diseases. Respir Res. 2011; 12:70.
PMC: 3128860.
DOI: 10.1186/1465-9921-12-70.
View
15.
Bryant A, Cerfolio R
. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest. 2007; 132(1):185-92.
DOI: 10.1378/chest.07-0442.
View
16.
Lofling L, Karimi A, Sandin F, Bahmanyar S, Kieler H, Lambe M
. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study. Acta Oncol. 2019; 58(11):1618-1627.
DOI: 10.1080/0284186X.2019.1638521.
View
17.
Smida T, Bruno T, Stabile L
. Influence of Estrogen on the NSCLC Microenvironment: A Comprehensive Picture and Clinical Implications. Front Oncol. 2020; 10:137.
PMC: 7039860.
DOI: 10.3389/fonc.2020.00137.
View
18.
Le Calvez F, Mukeria A, Hunt J, Kelm O, Hung R, Taniere P
. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 2005; 65(12):5076-83.
DOI: 10.1158/0008-5472.CAN-05-0551.
View
19.
Mukherjee T, Malik P, Hoidal J
. The emerging role of estrogen related receptorα in complications of non-small cell lung cancers. Oncol Lett. 2021; 21(4):258.
PMC: 7882887.
DOI: 10.3892/ol.2021.12519.
View
20.
. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014; 511(7511):543-50.
PMC: 4231481.
DOI: 10.1038/nature13385.
View